Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model

Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman and Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Frank Atkins
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas VanNostrand
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shari Moreau
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Burman
2Division of Endo;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Wartofsky
3Department of Medicine, Washington Hospital Center, Washington, District of Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 48 no. supplement 2 268P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 31, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Frank Atkins1,
  2. Douglas VanNostrand1,
  3. Shari Moreau1,
  4. Kenneth Burman2 and
  5. Leonard Wartofsky3
  1. 1Division of Nuclear Medicine;
  2. 2Division of Endo;
  3. 3Department of Medicine, Washington Hospital Center, Washington, District of Columbia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Jul 2015100
Sep 2015700
Oct 2015100
Jun 2016100
Sep 2016100
Oct 2016100
Dec 2016100
Jan 2017100
Mar 2017100
May 2017100
Jun 2017400
Jul 2017100
Aug 2017300
Sep 2017200
Oct 2017200
May 2018600
Jun 2018100
Sep 2018200
Nov 2019100
Dec 2019100
Mar 2020500
Apr 20201000
Jun 2020100
Jul 2020300
Aug 202010200
Sep 202011900
Oct 20201800
Nov 20201700
Dec 2020900
Jan 2021200
Feb 20211500
Mar 20216600
Apr 202112400
May 2021900
Jun 2021500
Jul 20211300
Aug 20213100
Sep 20211000
Oct 20211200
Nov 20218100
Dec 20213900
Jan 20226200
Feb 20222100
Mar 20221600
Apr 2022600
May 20222500
Jun 2022200
Aug 2022100
Dec 2022100
Jan 2023300
Mar 2023200
Apr 2023100
May 2023300
Jun 2023100
Jul 2023200
Aug 2023100
Sep 2023200
Oct 2023200
Nov 2023100
Dec 2023400
Jan 2024300
Feb 2024300
Mar 2024400
Apr 2024100
May 2024300
Jun 2024400
Jul 2024300
Aug 2024200
Sep 2024100
Oct 2024100
Nov 2024400
Dec 2024400
Jan 2025400
Feb 2025100
Mar 2025100
Apr 2025200
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman, Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman, Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Show more General Clinical Specialties: Endocrinology

Endocrinology Posters

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
Show more Endocrinology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire